New York and Washington consider bills to legalize the medical use of psilocybin, while Colorado voters might establish medical frameworks for psilocybin therapy this November.
Concerned scientists say that the proposal will inevitably hamper vital research of nearly 100 related compounds.
Canada has loosened restrictions for doctors to use MDMA and psilocybin to treatment-resistant conditions and terminally ill patients, but the approval process is slower than some patients can afford.
Pioneering research into psilocybin for treating veterans with PTSD has made Republicans like Rick Perry unlikely allies with Democrats in the Texas legislature.
On Tuesday, Detroit citizens passed a ballot that makes plant-based psychedelics the lowest priority for law enforcement.
Elected representatives across the country have proposed bills that would allow for research into psychedelics and others that would decriminalize psychedelic drugs at the state level.
The director of policy for MAPS discusses why ketamine was removed from the California decrim bill and the possible benefits of decriminalizing personal adult use of ketamine.
The bill, SB 519, is on hold to allow a coalition of supporters to build support for the bill among legislators.
In “smoke signal” to federal agencies, a House Committee report urges government funded psychedelic research.